Nanosonics Limited

ASX:NAN ISIN:AU000000NAN9

Nanosonics Limited is developing a portfolio of decontamination products designed to reduce the spread of infection. The Company owns intellectual property relating to a unique disinfection and sterilisation technology which can be suited to a variety of markets.<br /><br />Initial market applications are designed for the reprocessing of reusable medical instruments. The Company’s first product is designed to disinfect Ultrasound Transducers. In parallel with the commercialisation of this product, Nanosonics is also developing other medical applications and exploring opportunities for its proprietary technology in other industries. 
 
   

查看其它語言版本

新聞

3月30日亞洲市場縱覽

🕔3/30/2009 3:00:25 PM 19912

美國股市週五回落後,大多數亞洲股市週一交易日開市十分波動。東京和首爾市場開盤平淡,然後很快進入下跌區域。今天投資者也在等待美國政府公佈援助汽車工業的計劃。

閱讀全文
###

30,868 公司背景瀏覽

  • 本頁瀏覽人次: (過去7日: 14) (過去30日: 50) (自發布以來: 7237) 

公司詳細

更多新聞紀錄

  • 2024/03/25: Change of Director's Interest Notice*
  • 2024/03/15: Organisational Announcement Chief Technology Officer*
  • 2024/03/14: Ceasing to be a substantial holder for NAN*
  • 2024/03/08: Application for quotation of securities - NAN*
  • 2024/03/05: Change in substantial holding from MUFG*
  • 2024/03/04: Change in substantial holding*
  • 2024/03/04: Change of Director's Interest Notice*
  • 2024/03/04: Change of Director's Interest Notice*
  • 2024/02/29: Change of Director's Interest Notice*
  • 2024/02/29: Change of Director's Interest Notice*
*refer to company website